In addition the role may engages in peer-peer scientific and health economic discussions with relevant health care decision makers (HCDMs) and influencers within US public and private health care entities, including but not limited to, managed care organizations (MCOs), specialty pharmacy providers (SPPs), pharmaceutical benefit managers (PBMs), integrated delivery networks (IDNs), at designated centers and other health care networks. Delivers scientific presentations to formulary committees and other key healthcare decision makers (HCDMs), communicating the health economic model and supporting clinical data, and serves as the primary field-based resource to address questions related to these insights.